275 related articles for article (PubMed ID: 18359942)
21. Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis.
Sauane M; Su ZZ; Dash R; Liu X; Norris JS; Sarkar D; Lee SG; Allegood JC; Dent P; Spiegel S; Fisher PB
J Cell Physiol; 2010 Mar; 222(3):546-55. PubMed ID: 19937735
[TBL] [Abstract][Full Text] [Related]
22. Ceramide metabolism is affected by obesity and diabetes in human adipose tissue.
Błachnio-Zabielska AU; Pułka M; Baranowski M; Nikołajuk A; Zabielski P; Górska M; Górski J
J Cell Physiol; 2012 Feb; 227(2):550-7. PubMed ID: 21437908
[TBL] [Abstract][Full Text] [Related]
23. On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in mice.
Lijnen HR; Alessi MC; Van Hoef B; Collen D; Juhan-Vague I
J Thromb Haemost; 2005 Jun; 3(6):1174-9. PubMed ID: 15946208
[TBL] [Abstract][Full Text] [Related]
24. Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1.
Lijnen HR; Maquoi E; Morange P; Voros G; Van Hoef B; Kopp F; Collen D; Juhan-Vague I; Alessi MC
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):78-84. PubMed ID: 12524228
[TBL] [Abstract][Full Text] [Related]
25. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice.
Samad F; Loskutoff DJ
Mol Med; 1996 Sep; 2(5):568-82. PubMed ID: 8898373
[TBL] [Abstract][Full Text] [Related]
26. Food deprivation induces adipose plasminogen activator inhibitor-1 (PAI-1) expression without accumulation of plasma PAI-1 in genetically obese and diabetic db/db mice.
Oishi K; Ohkura N; Matsuda J; Ishida N
Thromb Haemost; 2007 Oct; 98(4):864-70. PubMed ID: 17938813
[TBL] [Abstract][Full Text] [Related]
27. Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice.
Deevska GM; Rozenova KA; Giltiay NV; Chambers MA; White J; Boyanovsky BB; Wei J; Daugherty A; Smart EJ; Reid MB; Merrill AH; Nikolova-Karakashian M
J Biol Chem; 2009 Mar; 284(13):8359-68. PubMed ID: 19074137
[TBL] [Abstract][Full Text] [Related]
28. Sphingomyelinase and cell-permeable ceramide analogs increase the release of plasminogen activator inhibitor-1 from cultured endothelial cells.
Soeda S; Honda O; Shimeno H; Nagamatsu A
Thromb Res; 1995 Dec; 80(6):509-18. PubMed ID: 8610279
[TBL] [Abstract][Full Text] [Related]
29. Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity.
Bastard JP; Piéroni L
Biomed Pharmacother; 1999 Dec; 53(10):455-61. PubMed ID: 10665338
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.
Ussher JR; Koves TR; Cadete VJ; Zhang L; Jaswal JS; Swyrd SJ; Lopaschuk DG; Proctor SD; Keung W; Muoio DM; Lopaschuk GD
Diabetes; 2010 Oct; 59(10):2453-64. PubMed ID: 20522596
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen activator inhibitor-1 deficiency ameliorates insulin resistance and hyperlipidemia but not bone loss in obese female mice.
Tamura Y; Kawao N; Yano M; Okada K; Matsuo O; Kaji H
Endocrinology; 2014 May; 155(5):1708-17. PubMed ID: 24605827
[TBL] [Abstract][Full Text] [Related]
32. Release of plasminogen activator inhibitor-1 from human astrocytes is regulated by intracellular ceramide.
Kimura M; Soeda S; Oda M; Ochiai T; Kihara T; Ono N; Shimeno H
J Neurosci Res; 2000 Dec; 62(6):781-8. PubMed ID: 11107162
[TBL] [Abstract][Full Text] [Related]
33. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.
Juhan-Vague I; Alessi MC; Morange PE
Ann Med; 2000 Dec; 32 Suppl 1():78-84. PubMed ID: 11209987
[TBL] [Abstract][Full Text] [Related]
34. Effects of pioglitazone and high-fat diet on ceramide metabolism in rat skeletal muscles.
Zendzian-Piotrowska M; Baranowski M; Zabielski P; Górski J
J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():101-14. PubMed ID: 17242494
[TBL] [Abstract][Full Text] [Related]
35. High fat diet induces ceramide and sphingomyelin formation in rat's liver nuclei.
Chocian G; Chabowski A; Zendzian-Piotrowska M; Harasim E; Łukaszuk B; Górski J
Mol Cell Biochem; 2010 Jul; 340(1-2):125-31. PubMed ID: 20174962
[TBL] [Abstract][Full Text] [Related]
36. Ceramides are necessary and sufficient for diet-induced impairment of thermogenic adipocytes.
Chaurasia B; Ying L; Talbot CL; Maschek JA; Cox J; Schuchman EH; Hirabayashi Y; Holland WL; Summers SA
Mol Metab; 2021 Mar; 45():101145. PubMed ID: 33352310
[TBL] [Abstract][Full Text] [Related]
37. Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction.
Lee SY; Kim JR; Hu Y; Khan R; Kim SJ; Bharadwaj KG; Davidson MM; Choi CS; Shin KO; Lee YM; Park WJ; Park IS; Jiang XC; Goldberg IJ; Park TS
J Biol Chem; 2012 May; 287(22):18429-39. PubMed ID: 22493506
[TBL] [Abstract][Full Text] [Related]
38. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentocnik JT; Stegnar M; Juhan-Vague I
Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
[TBL] [Abstract][Full Text] [Related]
39. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance.
Alessi MC; Poggi M; Juhan-Vague I
Curr Opin Lipidol; 2007 Jun; 18(3):240-5. PubMed ID: 17495595
[TBL] [Abstract][Full Text] [Related]
40. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.
Alessi MC; Bastelica D; Morange P; Berthet B; Leduc I; Verdier M; Geel O; Juhan-Vague I
Diabetes; 2000 Aug; 49(8):1374-80. PubMed ID: 10923640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
